We have 2 of 11 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
It is concluded that CRISPR-nanoparticle hybrids offer a transformative platform for precision antimicrobial intervention; however, no clinical trials currently exist for this specific application, and coordinated advances in nanoparticle engineering, safety characterization, and regulatory science are essential for cl...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
